The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors

Overexpression of the epidermal growth factor receptor (EGFR) is found in many cancers, including those of the head and neck area, non-small-cell lung cancer, and colorectal, cervical, prostate, breast, ovary, stomach, and pancreatic cancer. The EGFR inhibitors are used at present in the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Owczarek, Witold, Słowińska, Monika, Lesiak, Aleksandra, Ciążyńska, Magdalena, Maciąg, Aldona, Paluchowska, Elwira, Marek-Józefowicz, Luiza, Czajkowski, Rafał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831275/
https://www.ncbi.nlm.nih.gov/pubmed/29507555
http://dx.doi.org/10.5114/ada.2017.71106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831275/
https://www.ncbi.nlm.nih.gov/pubmed/29507555
http://dx.doi.org/10.5114/ada.2017.71106

Ejemplares similares